CRNX
Price
$28.87
Change
-$2.52 (-8.03%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
2.92B
35 days until earnings call
VKTX
Price
$24.22
Change
-$1.46 (-5.69%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
2.72B
20 days until earnings call
Ad is loading...

CRNX vs VKTX

Header iconCRNX vs VKTX Comparison
Open Charts CRNX vs VKTXBanner chart's image
Crinetics Pharmaceuticals
Price$28.87
Change-$2.52 (-8.03%)
Volume$22.65K
Capitalization2.92B
Viking Therapeutics
Price$24.22
Change-$1.46 (-5.69%)
Volume$49.74K
Capitalization2.72B
CRNX vs VKTX Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. VKTX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and VKTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (CRNX: $31.39 vs. VKTX: $25.68)
Brand notoriety: CRNX and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 117% vs. VKTX: 99%
Market capitalization -- CRNX: $2.69B vs. VKTX: $2.72B
CRNX [@Biotechnology] is valued at $2.69B. VKTX’s [@Biotechnology] market capitalization is $2.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 4 bullish TA indicator(s).

  • CRNX’s TA Score: 4 bullish, 4 bearish.
  • VKTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а -9.04% price change this week, while VKTX (@Biotechnology) price change was -2.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

CRNX is expected to report earnings on May 08, 2025.

VKTX is expected to report earnings on Apr 23, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.92B) has a higher market cap than VKTX($2.72B). VKTX YTD gains are higher at: -36.183 vs. CRNX (-38.607). VKTX has higher annual earnings (EBITDA): -150.58M vs. CRNX (-336.07M). CRNX has more cash in the bank: 1.35B vs. VKTX (903M). VKTX has less debt than CRNX: VKTX (1.12M) vs CRNX (51.7M). CRNX has higher revenues than VKTX: CRNX (1.04M) vs VKTX (0).
CRNXVKTXCRNX / VKTX
Capitalization2.92B2.72B107%
EBITDA-336.07M-150.58M223%
Gain YTD-38.607-36.183107%
P/E RatioN/AN/A-
Revenue1.04M0-
Total Cash1.35B903M150%
Total Debt51.7M1.12M4,620%
FUNDAMENTALS RATINGS
CRNX vs VKTX: Fundamental Ratings
CRNX
VKTX
OUTLOOK RATING
1..100
5876
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
6371
SMR RATING
1..100
9593
PRICE GROWTH RATING
1..100
8993
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8522

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (45) in the Biotechnology industry is somewhat better than the same rating for CRNX (89) in the Pharmaceuticals Major industry. This means that VKTX’s stock grew somewhat faster than CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (63) in the Pharmaceuticals Major industry is in the same range as VKTX (71) in the Biotechnology industry. This means that CRNX’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's SMR Rating (93) in the Biotechnology industry is in the same range as CRNX (95) in the Pharmaceuticals Major industry. This means that VKTX’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Price Growth Rating (89) in the Pharmaceuticals Major industry is in the same range as VKTX (93) in the Biotechnology industry. This means that CRNX’s stock grew similarly to VKTX’s over the last 12 months.

CRNX's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as VKTX (100) in the Biotechnology industry. This means that CRNX’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXVKTX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
68%
N/A
View a ticker or compare two or three
Ad is loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RTDRX14.730.08
+0.55%
Russell Inv Multifactor US Equity R6
RERAX52.140.15
+0.29%
American Funds Europacific Growth R1
WMBLX13.00N/A
N/A
WesMark Balanced
IAUYX26.45N/A
N/A
Invesco Dividend Income Y
PSMVX10.74N/A
N/A
Principal SmallCap Value II R6

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with ELVN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then ELVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+2.51%
ELVN - CRNX
51%
Loosely correlated
+5.19%
TRDA - CRNX
49%
Loosely correlated
+0.46%
DNLI - CRNX
49%
Loosely correlated
+11.80%
INZY - CRNX
48%
Loosely correlated
+6.48%
IDYA - CRNX
48%
Loosely correlated
+10.70%
More